Low levels of serum adiponectin are associated with obesity, metabolic syndrome, DM, HT, and CAD [35], and high levels of serum adiponectin are associated with chronic heart failure, poor cardiac function, and high mortality, especially in patients with chronic kidney disease (CKD) [34,36]. Here, ADIPOQ is linked to obesity disorder.